Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy

HIGHLIGHTS

• who: Andrea Anichini from the IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan, Italy have published the Article: Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy, in the Journal: (JOURNAL)
• what: The authors focused on the guadecitabine and JQ1 signatures and tested their prognostic significance in 41 tumor types of the TCGA cancer genome atlas using the outcome module of the TIMER2.0 web server (http://u200b timer.u200bcomp-u200bgenomu200bics.u200borg).
• how: Taken together these results indicated that the biological activity of guadecitabine as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.